My Quote Request
No products added yet
6505-01-518-2962
20 Products
NDC00409-2290-31
DIPHENHYDRAMINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505015182962
NSN
6505-01-518-2962
NDC00409-2290-31
DIPHENHYDRAMINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505015182962
NSN
6505-01-518-2962
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS DIPHENHYDRAMINE HYDROCHLORIDE PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 040404
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP 50 MG/ML 1ML CARPUJECT LEURLOCK 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: LUER LOCK CARPUJECT
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
04-0294
CALCIUM ACETATE AND
NSN, MFG P/N
6505015186525
NSN
6505-01-518-6525
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 841200
SPECIAL FEATURES: CALCIUM ACETATE AND ALUMINUM SULFATE POWDER FOR TOPICAL SOLUTION, 100 PACKETS PER PKG
Related Searches:
DOMEBORO POWDER
CALCIUM ACETATE AND
NSN, MFG P/N
6505015186525
NSN
6505-01-518-6525
MFG
SIEMENS HEALTHCARE DIAGNOSTICS INC . DIV SIEMENS HEALTHCARE DIAGNOSTICS
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 841200
SPECIAL FEATURES: CALCIUM ACETATE AND ALUMINUM SULFATE POWDER FOR TOPICAL SOLUTION, 100 PACKETS PER PKG
Related Searches:
NDC16500-0023-22
CALCIUM ACETATE AND
NSN, MFG P/N
6505015186525
NSN
6505-01-518-6525
MFG
CARDINAL HEALTH INC. DBA CARDINAL HEALTH
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 841200
SPECIAL FEATURES: CALCIUM ACETATE AND ALUMINUM SULFATE POWDER FOR TOPICAL SOLUTION, 100 PACKETS PER PKG
Related Searches:
04-0051
SODIUM HYALURONATE INJECTION
NSN, MFG P/N
6505015188234
NSN
6505-01-518-8234
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 14.000 MILLIGRAMS SODIUM HYALURONATE PER MILLILITER
ADMINISTRATION: INTRAOCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEALON GV 14MG PER ML 0.85 ML GLASS SYRINGE WITH 27 GAGE CANNULA
PRIMARY CONTAINER CONTENT QUANTITY: 0.850 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: IN DISPOSABLE GLASS SYRINGE WITH STERILE SINGLE USE 27 GAGE CANNULA; REFRIGERATED HEALON GV SHOULD BE HELD AT ROOM TEMP FOR APPROX 30 MINUTES BEFORE USE; PROTECT FROM FREEZING AND EXPOSURE TO LIGHT; FOR USE IN ANTERIOR SEGMENT OPHTHALMIC SURGICAL
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: PROCEDURES
Related Searches:
6515NCM040015
SODIUM HYALURONATE INJECTION
NSN, MFG P/N
6505015188234
NSN
6505-01-518-8234
6515NCM040015
SODIUM HYALURONATE INJECTION
NSN, MFG P/N
6505015188234
NSN
6505-01-518-8234
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 14.000 MILLIGRAMS SODIUM HYALURONATE PER MILLILITER
ADMINISTRATION: INTRAOCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEALON GV 14MG PER ML 0.85 ML GLASS SYRINGE WITH 27 GAGE CANNULA
PRIMARY CONTAINER CONTENT QUANTITY: 0.850 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: IN DISPOSABLE GLASS SYRINGE WITH STERILE SINGLE USE 27 GAGE CANNULA; REFRIGERATED HEALON GV SHOULD BE HELD AT ROOM TEMP FOR APPROX 30 MINUTES BEFORE USE; PROTECT FROM FREEZING AND EXPOSURE TO LIGHT; FOR USE IN ANTERIOR SEGMENT OPHTHALMIC SURGICAL
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: PROCEDURES
Related Searches:
NDC00016-0319-85
SODIUM HYALURONATE INJECTION
NSN, MFG P/N
6505015188234
NSN
6505-01-518-8234
NDC00016-0319-85
SODIUM HYALURONATE INJECTION
NSN, MFG P/N
6505015188234
NSN
6505-01-518-8234
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 14.000 MILLIGRAMS SODIUM HYALURONATE PER MILLILITER
ADMINISTRATION: INTRAOCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEALON GV 14MG PER ML 0.85 ML GLASS SYRINGE WITH 27 GAGE CANNULA
PRIMARY CONTAINER CONTENT QUANTITY: 0.850 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: IN DISPOSABLE GLASS SYRINGE WITH STERILE SINGLE USE 27 GAGE CANNULA; REFRIGERATED HEALON GV SHOULD BE HELD AT ROOM TEMP FOR APPROX 30 MINUTES BEFORE USE; PROTECT FROM FREEZING AND EXPOSURE TO LIGHT; FOR USE IN ANTERIOR SEGMENT OPHTHALMIC SURGICAL
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: PROCEDURES
Related Searches:
04-0299
LORAZEPAM INJECTION,USP
NSN, MFG P/N
6505015189609
NSN
6505-01-518-9609
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS LORAZEPAM PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 282408
FEATURES PROVIDED: STERILE
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE IV
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORAZEPAM INJECTION USP 4MG/ML 10 ML MULTI-DOSE VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PHARMACEUTICAL VEHICLE TYPE: PROPYLENE GLYCOL AND POLYETHYLENE GLYCOL AND BENZYL ALCOHOL
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: FLIPTOP VIAL, PROTECT FROM LIGHT; USE CARTON TO PROTECT CONTENTS FROM LIGHT
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00409-6781-02
LORAZEPAM INJECTION,USP
NSN, MFG P/N
6505015189609
NSN
6505-01-518-9609
NDC00409-6781-02
LORAZEPAM INJECTION,USP
NSN, MFG P/N
6505015189609
NSN
6505-01-518-9609
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS LORAZEPAM PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 282408
FEATURES PROVIDED: STERILE
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE IV
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORAZEPAM INJECTION USP 4MG/ML 10 ML MULTI-DOSE VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PHARMACEUTICAL VEHICLE TYPE: PROPYLENE GLYCOL AND POLYETHYLENE GLYCOL AND BENZYL ALCOHOL
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: FLIPTOP VIAL, PROTECT FROM LIGHT; USE CARTON TO PROTECT CONTENTS FROM LIGHT
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC55390-0171-10
LORAZEPAM INJECTION,USP
NSN, MFG P/N
6505015189609
NSN
6505-01-518-9609
NDC55390-0171-10
LORAZEPAM INJECTION,USP
NSN, MFG P/N
6505015189609
NSN
6505-01-518-9609
MFG
BEN VENUE LABORATORIES INC DBA BEDFORD LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS LORAZEPAM PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 282408
FEATURES PROVIDED: STERILE
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE IV
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORAZEPAM INJECTION USP 4MG/ML 10 ML MULTI-DOSE VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PHARMACEUTICAL VEHICLE TYPE: PROPYLENE GLYCOL AND POLYETHYLENE GLYCOL AND BENZYL ALCOHOL
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: FLIPTOP VIAL, PROTECT FROM LIGHT; USE CARTON TO PROTECT CONTENTS FROM LIGHT
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
04-0298
LORAZEPAM INJECTION,USP
NSN, MFG P/N
6505015189650
NSN
6505-01-518-9650
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS LORAZEPAM PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 282402
FEATURES PROVIDED: STERILE
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE IV
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORAZEPAM INJECTION USP 2MG/ML 10 ML MULTI-DOSE VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PHARMACEUTICAL VEHICLE TYPE: PROPYLENE GLYCOL AND POLYETHYLENE GLYCOL AND BENZYL ALCOHOL
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: FLIPTOP VIAL, PROTECT FROM LIGHT; USE CARTON TO PROTECT CONTENTS FROM LIGHT
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00074-6780-02
LORAZEPAM INJECTION,USP
NSN, MFG P/N
6505015189650
NSN
6505-01-518-9650
NDC00074-6780-02
LORAZEPAM INJECTION,USP
NSN, MFG P/N
6505015189650
NSN
6505-01-518-9650
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS LORAZEPAM PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 282402
FEATURES PROVIDED: STERILE
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE IV
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORAZEPAM INJECTION USP 2MG/ML 10 ML MULTI-DOSE VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PHARMACEUTICAL VEHICLE TYPE: PROPYLENE GLYCOL AND POLYETHYLENE GLYCOL AND BENZYL ALCOHOL
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: FLIPTOP VIAL, PROTECT FROM LIGHT; USE CARTON TO PROTECT CONTENTS FROM LIGHT
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
04-0300
BALSALAZIDE DISODIU
NSN, MFG P/N
6505015191078
NSN
6505-01-519-1078
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 563600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BALSALAZIDE DISODIUM CAPSULES BT 280S
SPECIAL FEATURES: 750 MG BALSALAZIDE DISODIUM; STORE AT 25 DEG C (77 DEG F); FOR TX OF ACTIVE ULCERATIVE COLITIS, CAN BE USED AS AN ANTI-INFLAMMATORY, GASTROINTESTINAL, 280 CAPSULES PER BT
Related Searches:
COLAZAL
BALSALAZIDE DISODIU
NSN, MFG P/N
6505015191078
NSN
6505-01-519-1078
MFG
SALIX PHARMACEUTICALS INC.
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 563600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BALSALAZIDE DISODIUM CAPSULES BT 280S
SPECIAL FEATURES: 750 MG BALSALAZIDE DISODIUM; STORE AT 25 DEG C (77 DEG F); FOR TX OF ACTIVE ULCERATIVE COLITIS, CAN BE USED AS AN ANTI-INFLAMMATORY, GASTROINTESTINAL, 280 CAPSULES PER BT
Related Searches:
NDC65649-0101-02
BALSALAZIDE DISODIU
NSN, MFG P/N
6505015191078
NSN
6505-01-519-1078
MFG
SALIX PHARMACEUTICALS INC.
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 563600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BALSALAZIDE DISODIUM CAPSULES BT 280S
SPECIAL FEATURES: 750 MG BALSALAZIDE DISODIUM; STORE AT 25 DEG C (77 DEG F); FOR TX OF ACTIVE ULCERATIVE COLITIS, CAN BE USED AS AN ANTI-INFLAMMATORY, GASTROINTESTINAL, 280 CAPSULES PER BT
Related Searches:
NDC00003-1457-05
ALGINATE TOPICAL GE
NSN, MFG P/N
6505015191079
NSN
6505-01-519-1079
MFG
BRISTOL-MYERS SQUIBB PHARMA COMPANY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALGINATE TOPICAL GEL F/WOUND CLEANSING/DRESSING 85GRAMS 3OZ TUBE 12S
III SUPPLEMENTARY FEATURES: 3 OZ TUBE OR 85 GRAMS
SPECIAL FEATURES: DERMAL HYDRATING GEL USED TO PROMOTE WOUND HEALING; 85 GRAMS, 3OZ. TUBE, 12 TUBES PER PACKAGE; THIS ALGINATE-CONTAINING WOUND GEL MAY BE USED IN THE MANAGEMENT OF CHRONIC WOUNDS, INCLUDING STAGE IV WOUND; FOR MANAGEMENT OF PRESSURE ULCERS, STASIS ULCERS,
~1: FIRST AND SECOND DEGREE BURNS, CUTS, ABRASIONS AND SKIN TEARS; REMAINS EFFECTIVE FOR UP TO 28 DAYS AFTER OPENING
Related Searches:
0883-400ML
PHENOL,CHLOROFORM
NSN, MFG P/N
6505015191897
NSN
6505-01-519-1897
MFG
AMRESCO INC.
Description
III STORAGE TEMP RANGE: 2.0 TO 8.0 DEG CELSIUS
SPECIAL FEATURES: PREMIXED WITH ISOAMYL ALCOHOL; BIOTECHNOLOGY GRADE; PURITY 99.0 PERCENT MAX; SIZE 400.0 MICROLITERS
Related Searches:
0408-10G
KANAMYCIN SULFATE CAPSULES,USP
NSN, MFG P/N
6505015192315
NSN
6505-01-519-2315
0408-10G
KANAMYCIN SULFATE CAPSULES,USP
NSN, MFG P/N
6505015192315
NSN
6505-01-519-2315
MFG
AMRESCO INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 GRAMS KANAMYCIN SULFATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
SPECIAL FEATURES: USP GRADE; STORAGE TEMPERATURE PLUS 18.0 DEG C TO PLUS 26.0 DEG C; PH (1 PERCENT, WATER) @25 DEG C 6.5-8.5; LOSS ON DRYING 4.0 PERCENT MAX
Related Searches:
0833-500G
CETYLTRIMETHYLAMMON
NSN, MFG P/N
6505015192316
NSN
6505-01-519-2316
MFG
AMRESCO INC.
Description
III STORAGE TEMP RANGE: 18.0 TO 26.0 DEG CELSIUS
SPECIAL FEATURES: HIGH PURITY GRADE; PURITY 99.0 PERCENT MIN; SIZE 500.0 GRAMS; HAZARD TYPES CORROSIVE, TOXIC AND IRRITANT
Related Searches:
0319-25MU
POLYMIXIN B SULFATE
NSN, MFG P/N
6505015192318
NSN
6505-01-519-2318
MFG
AMRESCO INC.
Description
III STORAGE TEMP RANGE: 2.0 TO 8.0 DEG CELSIUS
SPECIAL FEATURES: USP GRADE; LOSS ON DRYING 7.0 PERCENT MAX; PH (0.5 PERCENT, WATER) @ 25C 5.0 TO 7.5 PERCENT; RESIDUE AFTER IGNITION 5.0 PERCENT MAX; SIZE 25.0 MICRO UNITS
